2020 KSGE临床实践指南:早期胃肠道肿瘤内镜切除术

2020-03-20 韩国胃肠内镜学会 Clin Endosc. 2020 Mar;53(2):142-166.

虽然手术是早期胃肠道肿瘤的标准治疗方法,但内镜切除术现在是不存在局部淋巴结转移的早期胃肠道肿瘤的标准治疗方法。本文作为韩国首部早期胃肠道肿瘤内镜切除指南,主要针对浅表性食管鳞状细胞癌,早期胃癌,早期结

中文标题:

2020 KSGE临床实践指南:早期胃肠道肿瘤内镜切除术

英文标题:

Clinical Practice Guideline for Endoscopic Resection of Early Gastrointestinal Cancer.

发布机构:

韩国胃肠内镜学会

发布日期:

2020-03-20

简要介绍:

虽然手术是早期胃肠道肿瘤的标准治疗方法,但内镜切除术现在是不存在局部淋巴结转移的早期胃肠道肿瘤的标准治疗方法。本文作为韩国首部早期胃肠道肿瘤内镜切除指南,主要针对浅表性食管鳞状细胞癌,早期胃癌,早期结肠癌的治疗提供指导。

 

相关资料下载:
[AttachmentFileName(sort=1, fileName=)] GetToolGuiderByIdResponse(projectId=1, id=f92231c001890949, title=2020 KSGE临床实践指南:早期胃肠道肿瘤内镜切除术, enTitle=Clinical Practice Guideline for Endoscopic Resection of Early Gastrointestinal Cancer., guiderFrom=Clin Endosc. 2020 Mar;53(2):142-166., authorId=0, author=, summary=虽然手术是早期胃肠道肿瘤的标准治疗方法,但内镜切除术现在是不存在局部淋巴结转移的早期胃肠道肿瘤的标准治疗方法。本文作为韩国首部早期胃肠道肿瘤内镜切除指南,主要针对浅表性食管鳞状细胞癌,早期胃癌,早期结, cover=https://img.medsci.cn/2020414/1586863740168_2020535.jpg, journalId=0, articlesId=null, associationId=1404, associationName=韩国胃肠内镜学会, associationIntro=, copyright=0, guiderPublishedTime=Fri Mar 20 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>虽然手术是早期胃肠道肿瘤的标准治疗方法,但内镜切除术现在是不存在局部淋巴结转移的早期胃肠道肿瘤的标准治疗方法。本文作为韩国首部早期胃肠道肿瘤内镜切除指南,主要针对浅表性食管鳞状细胞癌,早期胃癌,早期结肠癌的治疗提供指导。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=102592, tagName=早期胃肠道肿瘤)], categoryList=[CategoryDto(categoryId=4, categoryName=消化, tenant=100), CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=76, categoryName=胃肠外科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=20620, categoryName=肿瘤医学网, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=1292, guiderKeyword=胃肠道肿瘤, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=1652, appHits=89, showAppHits=0, pcHits=524, showPcHits=1584, likes=1, shares=5, comments=2, approvalStatus=1, publishedTime=Tue Apr 14 19:53:13 CST 2020, publishedTimeString=2020-03-20, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Tue Apr 14 19:29:02 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 18:09:29 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=)])
下载请点击:
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1082366, encodeId=a59b108236674, content=学习好资料!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Tue Dec 21 08:43:10 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016572, encodeId=84b010165e2c3, content=好文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=551b5602090, createdName=ms8000000342752332, createdTime=Sat Sep 11 16:08:37 CST 2021, time=2021-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=381722, encodeId=d071381e2292, content=好文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/loWCdYSmWU0oJEboeicXeh78rLKj9021tib6AlDCp1CoxibG9x13FibEYNRicISETAM8B9FHia9oKJNqPd8fibkbIwojA/132, createdBy=29825318903, createdName=weiqizhu, createdTime=Wed Apr 15 09:18:53 CST 2020, time=2020-04-15, status=1, ipAttribution=)]
    2021-12-21 龙珠

    学习好资料!

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1082366, encodeId=a59b108236674, content=学习好资料!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Tue Dec 21 08:43:10 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016572, encodeId=84b010165e2c3, content=好文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=551b5602090, createdName=ms8000000342752332, createdTime=Sat Sep 11 16:08:37 CST 2021, time=2021-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=381722, encodeId=d071381e2292, content=好文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/loWCdYSmWU0oJEboeicXeh78rLKj9021tib6AlDCp1CoxibG9x13FibEYNRicISETAM8B9FHia9oKJNqPd8fibkbIwojA/132, createdBy=29825318903, createdName=weiqizhu, createdTime=Wed Apr 15 09:18:53 CST 2020, time=2020-04-15, status=1, ipAttribution=)]
    2021-09-11 ms8000000342752332

    好文章

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1082366, encodeId=a59b108236674, content=学习好资料!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Tue Dec 21 08:43:10 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016572, encodeId=84b010165e2c3, content=好文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=551b5602090, createdName=ms8000000342752332, createdTime=Sat Sep 11 16:08:37 CST 2021, time=2021-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=381722, encodeId=d071381e2292, content=好文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/loWCdYSmWU0oJEboeicXeh78rLKj9021tib6AlDCp1CoxibG9x13FibEYNRicISETAM8B9FHia9oKJNqPd8fibkbIwojA/132, createdBy=29825318903, createdName=weiqizhu, createdTime=Wed Apr 15 09:18:53 CST 2020, time=2020-04-15, status=1, ipAttribution=)]
    2020-04-15 weiqizhu

    好文章

    0

拓展阅读

【中文译文】2022 共识声明:胃肠道恶性肿瘤患者的监测

国外肿瘤科相关专家小组(统称) · 2022-05-26

循环肿瘤细胞检测在胃肠道肿瘤诊疗中的应用中国专家共识(2023版)

中国医师协会结直肠肿瘤专业委员会 · 2023-12-04